ArticleHealth science reports2025
Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Re-emerging infectious diseases pose significant public health challenges in Africa and demand robust and coordinated responses. The Mpox virus (MPXV) has increasingly caused outbreaks with global implications, highlighting the vulnerabilities of the continent's health systems. As of April 2025, the African region has reported over 35,833 confirmed cases and 135 deaths, highlighting the urgent need to strengthen public health strategies. This review examines the lessons learned from MPXV outbreaks in Africa, emphasizing the importance of adaptive public health responses in preventing future re-emerging infectious diseases. Methods: This review synthesized data from peer-reviewed articles, the World Health Organization (WHO) reports, and authoritative sources accessed through PubMed and other databases. We analyzed existing public health responses, infrastructure, community engagement, and international collaborations related to MPXV outbreaks in Africa, identifying gaps and opportunities for strengthening responses to re-emerging infectious diseases. Results: We identified key shortcomings in Africa's public health capacity, including insufficient funding, limited disease surveillance, constraints in diagnostic infrastructure, social stigma, and misinformation. Successful response strategies include regional coordination, vaccine procurement and deployment, enhanced laboratory capacity, and community engagement efforts. The lessons learned highlight the importance of sustainable funding, integrated one health approaches, and global partnerships in improving outbreak preparedness and response. Conclusions: Building resilient health systems, fostering international collaboration, and engaging communities are pivotal for controlling re-emerging infectious diseases in Africa. Strategic investments in disease surveillance, diagnostic capacity, vaccination, and health education, coupled with a multi-sectoral approach, are essential for enhancing outbreak preparedness and achieving health security. The insights from MPXV outbreaks provide valuable guidance for policymakers and health practitioners aiming to strengthen Africa's public health response to future infectious disease threats.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.